Remel Escherichia coli Agglutinating Sera - HSA Registration DE0015999
Access comprehensive regulatory information for Remel Escherichia coli Agglutinating Sera in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0015999 and owned by Remel Europe Limited. The device was registered on July 17, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Escherichia coli Agglutinating Sera are intended for use in agglutination tests for the presumptive identification of E. coli serotypes traditionally associated with infantile gastroenteritis. However, since antigenic components are shared widely throughout the Enterobacteriaceae it is important to confirm by biochemical tests that an organism is of the species E. coli when attempting serological identification.